ORAGENICS, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
ORAGENICS, INC. (OGEN) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $232.18 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2019-11-14
- ORAGENICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2019-09-30 was $232.18K, a 64.19% decline year-over-year.
- ORAGENICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2019-06-30 was $164.59K, a 100.75% increase year-over-year.
- ORAGENICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2019-03-31 was $145.83K, a 23.25% increase year-over-year.
- ORAGENICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2018-09-30 was $648.30K.
- ORAGENICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2018 was $996.04K, a 128.86% increase from fiscal 2017.
- ORAGENICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2017 was $435.22K, a 7.95% decline from fiscal 2016.
- ORAGENICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2016 was $472.78K, a 38.66% decline from fiscal 2015.
- ORAGENICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2015 was $770.70K, a 317.65% increase from fiscal 2014.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2019-09-30 | $232.18K 10-Q · filed 2019-11-14 | $396.76K derived: sum of 2 quarters · filed 2019-11-14 | $542.59K derived: sum of 3 quarters · filed 2019-11-14 | |
| 2019-06-30 | $164.59K 10-Q · filed 2019-11-14 | $310.42K derived: sum of 2 quarters · filed 2019-11-14 | ||
| 2019-03-31 | $145.83K 10-Q · filed 2019-11-14 | |||
| 2018-12-31 | $996.04K 10-K · filed 2019-03-29 | |||
| 2018-09-30 | $648.30K 10-Q · filed 2019-11-14 | $730.29K derived: sum of 2 quarters · filed 2019-11-14 | $848.61K derived: sum of 3 quarters · filed 2019-11-14 | |
| 2018-06-30 | $81.99K 10-Q · filed 2019-11-14 | $200.31K derived: sum of 2 quarters · filed 2019-11-14 | ||
| 2018-03-31 | $118.32K 10-Q · filed 2019-11-14 | |||
| 2017-12-31 | $435.22K 10-K · filed 2019-03-29 | |||
| 2016-12-31 | $472.78K 10-K · filed 2018-02-16 | |||
| 2015-12-31 | $770.70K 10-K · filed 2017-02-27 | |||
| 2014-12-31 | $184.53K 10-K · filed 2016-03-30 | |||
| 2013-12-31 | $191.20K 10-K · filed 2015-02-27 | |||
| 2012-12-31 | $229.50K 10-K · filed 2014-02-28 | |||
| 2011-12-31 | $1.14M 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |